World Heart Corporation - Sales Analysis Snapshot

Business Description
This Report provides a comprehensive Sales & Margin summary analysis for World Heart Corporation Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.

World Heart Corporation. The Group's principal activity is to develop artificial heart technologies. The Group is focused on two technologies: Novacor LVAS and the HeartSaver Ventricular Assist Device (HeartSaver). Novacor technology is currently in commercial production and the HeartSaver technology is currently under development. This technology is being developed from licensed artificial heart and related technologies developed by the Cardiovascular Devices Division (CVD) of the Ottawa Heart Institute Research Corporation. The Group operates in Canada and the United States.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report